{"transactions":[{"id":2013154,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":116827,"kind":"person","name":"Shearman Mark S","position":1,"cik":"0001643799","reported_name":"Shearman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2023-02-15T16:30:45.000Z","date":"2023-02-13","kind":"sale","acquired":false,"shares":2790,"price":9.6653,"value":26966.187,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 19, 2021 and represents the sale of shares necessary to meet tax withholding obligations as a result of vesting in restricted stock units on February 10, 2023. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":65559,"source":{"system":"sec-edgar","filing":"0001415889-23-002604","document":"form4-02152023_040213.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643799/000141588923002604/form4-02152023_040213.xml","form_type":"4"}},{"id":2229443,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":116827,"kind":"person","name":"Shearman Mark S","position":1,"cik":"0001643799","reported_name":"Shearman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2022-06-16T16:15:15.000Z","date":"2022-06-15","kind":"sale","acquired":false,"shares":5145,"price":10.0573,"value":51744.8085,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on April 19, 2021 and represents the sale of shares necessary to meet tax withholding obligations as a result of vesting in restricted stock units and in performance stock units on June 14, 2022. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":68349,"source":{"system":"sec-edgar","filing":"0001415889-22-006631","document":"form4-06162022_040601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643799/000141588922006631/form4-06162022_040601.xml","form_type":"4"}},{"id":2400912,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":116827,"kind":"person","name":"Shearman Mark S","position":1,"cik":"0001643799","reported_name":"Shearman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-11T16:21:17.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":93398,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on February 10, 2022 and is scheduled to vest over four years in equal monthly installments beginning on March 10, 2022 through February 10, 2026."}],"balance_after":93398,"derivative":{"exercise_price":17.29,"expiration_date":"2032-02-09","underlying":"Common Stock","underlying_shares":93398},"source":{"system":"sec-edgar","filing":"0001415889-22-001224","document":"form4-02112022_010249.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1643799/000141588922001224/form4-02112022_010249.xml","form_type":"4"}},{"id":2400911,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":116827,"kind":"person","name":"Shearman Mark S","position":1,"cik":"0001643799","reported_name":"Shearman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2022-02-11T16:21:17.000Z","date":"2022-02-10","kind":"grant","acquired":true,"shares":31709,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years with 25% of the units vesting on February 10, 2023 and the remaining 75% of the units scheduled to vest in equal quarterly installments thereafter through February 10, 2026."}],"balance_after":73494,"source":{"system":"sec-edgar","filing":"0001415889-22-001224","document":"form4-02112022_010249.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643799/000141588922001224/form4-02112022_010249.xml","form_type":"4"}},{"id":2459270,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":116827,"kind":"person","name":"Shearman Mark S","position":1,"cik":"0001643799","reported_name":"Shearman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-12-23T16:10:36.000Z","date":"2021-12-22","kind":"grant","acquired":true,"shares":9084,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the acquisition, upon the achievement of a specified research and development milestone, of a portion of a performance-based restricted stock unit award originally granted on June 14, 2021. The shares subject to the restricted stock unit award remain subject to time-based vesting conditions and will vest on June 14, 2022, subject to continued service."}],"balance_after":41785,"source":{"system":"sec-edgar","filing":"0001179110-21-011225","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643799/000117911021011225/edgar.xml","form_type":"4"}},{"id":2665487,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":116827,"kind":"person","name":"Shearman Mark S","position":1,"cik":"0001643799","reported_name":"Shearman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2021-06-16T16:19:04.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":52718,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on June 14, 2021 and is scheduled to vest over four years, with 25% of the shares to vest on June 14, 2022 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through June 14, 2025."}],"balance_after":52718,"derivative":{"exercise_price":38.53,"expiration_date":"2031-06-13","underlying":"Common Stock","underlying_shares":52718},"source":{"system":"sec-edgar","filing":"0001179110-21-006778","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1643799/000117911021006778/edgar.xml","form_type":"4"}},{"id":2665486,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":116827,"kind":"person","name":"Shearman Mark S","position":1,"cik":"0001643799","reported_name":"Shearman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-06-16T16:19:04.000Z","date":"2021-06-14","kind":"grant","acquired":true,"shares":32701,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years in equal yearly installments of one-fourth of the shares, with the first such installment to vest on June 14, 2022 continuing through June 14, 2025."}],"balance_after":32701,"source":{"system":"sec-edgar","filing":"0001179110-21-006778","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1643799/000117911021006778/edgar.xml","form_type":"4"}},{"id":3053791,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":116827,"kind":"person","name":"Shearman Mark S","position":1,"cik":"0001643799","reported_name":"Shearman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2020-08-18T18:15:53.000Z","date":"2020-08-15","kind":"tax_withholding","acquired":false,"shares":5723,"price":5.77,"value":33021.71,"ownership":{"direct":true},"balance_after":33277,"source":{"system":"sec-edgar","filing":"0001273636-20-000004","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000127363620000004/edgar.xml","form_type":"4"}},{"id":3064598,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":116827,"kind":"person","name":"Shearman Mark S","position":1,"cik":"0001643799","reported_name":"Shearman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2020-08-07T20:07:37.000Z","date":"2020-08-05","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable in equal monthly installments over four years from the date of grant."}],"balance_after":50000,"derivative":{"exercise_price":5.5,"expiration_date":"2030-08-05","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-20-021803","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000089924320021803/doc4.xml","form_type":"4"}},{"id":3434284,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":116827,"kind":"person","name":"Shearman Mark S","position":1,"cik":"0001643799","reported_name":"Shearman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-08-19T19:57:44.000Z","date":"2019-08-15","kind":"grant","acquired":true,"shares":52000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option becomes exercisable in equal monthly installments over four years from the date of grant."}],"balance_after":52000,"derivative":{"exercise_price":3,"expiration_date":"2029-08-15","underlying":"Common Stock","underlying_shares":52000},"source":{"system":"sec-edgar","filing":"0001273636-19-000035","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000127363619000035/edgar.xml","form_type":"4"}},{"id":3434283,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":116827,"kind":"person","name":"Shearman Mark S","position":1,"cik":"0001643799","reported_name":"Shearman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2019-08-19T19:57:44.000Z","date":"2019-08-15","kind":"grant","acquired":true,"shares":39000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") under the Applied Genetic Technologies Corporation (\"AGTC\") 2013 Equity and Incentive Plan. Each RSU represents the contingent right to receive, upon vesting of the unit, one share of AGTC common stock. The RSUs vest annually over two years beginning on the date of grant, with all such vesting contingent on the achievement of the average of the closing price per share of AGTC common stock, as quoted on the Nasdaq Global Market, over a consecutive, 30 trading day period reaching or exceeding $3.75 per share."}],"balance_after":39000,"source":{"system":"sec-edgar","filing":"0001273636-19-000035","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000127363619000035/edgar.xml","form_type":"4"}},{"id":3726516,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":116827,"kind":"person","name":"Shearman Mark S","position":1,"cik":"0001643799","reported_name":"Shearman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2018-12-18T19:58:18.000Z","date":"2018-12-14","kind":"sale","acquired":false,"shares":3000,"price":3.3509,"value":10052.7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $3.35 to $3.36, inclusive. The reporting person undertakes to provide to Applied Genetic Technologies Corporation (\"AGTC\"), any security holder of AGTC, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001273636-18-000081","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000127363618000081/edgar.xml","form_type":"4"}},{"id":3859876,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":116827,"kind":"person","name":"Shearman Mark S","position":1,"cik":"0001643799","reported_name":"Shearman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-07-27T17:05:16.000Z","date":"2018-07-25","kind":"grant","acquired":true,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable in equal monthly installments over four years from the date of grant."}],"balance_after":85000,"derivative":{"exercise_price":4.25,"expiration_date":"2028-07-25","underlying":"Common Stock","underlying_shares":85000},"source":{"system":"sec-edgar","filing":"0001273636-18-000022","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000127363618000022/edgar.xml","form_type":"4"}},{"id":4255161,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":116827,"kind":"person","name":"Shearman Mark S","position":1,"cik":"0001643799","reported_name":"Shearman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option  (right to buy)","published_at":"2017-07-18T20:40:12.000Z","date":"2017-07-17","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option becomes exercisable in equal monthly installments over four years from the date of grant."}],"balance_after":50000,"derivative":{"exercise_price":4.9,"expiration_date":"2027-07-17","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0000899243-17-018472","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000089924317018472/doc4.xml","form_type":"4"}},{"id":4594992,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":116827,"kind":"person","name":"Shearman Mark S","position":1,"cik":"0001643799","reported_name":"Shearman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2016-09-26T17:20:08.000Z","date":"2016-09-22","kind":"purchase","acquired":true,"shares":1300,"price":8.87,"value":11531.0,"ownership":{"direct":true},"balance_after":3000,"source":{"system":"sec-edgar","filing":"0000899243-16-030015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000089924316030015/doc4.xml","form_type":"4"}},{"id":4594991,"issuer":{"id":121949,"kind":"organization","name":"APPLIED GENETIC TECHNOLOGIES CORP","symbol":"AGTC"},"owners":[{"id":116827,"kind":"person","name":"Shearman Mark S","position":1,"cik":"0001643799","reported_name":"Shearman Mark S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2016-09-26T17:20:08.000Z","date":"2016-09-22","kind":"purchase","acquired":true,"shares":1700,"price":8.865,"value":15070.5,"ownership":{"direct":true},"balance_after":1700,"source":{"system":"sec-edgar","filing":"0000899243-16-030015","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1273636/000089924316030015/doc4.xml","form_type":"4"}}]}